Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated Phase 3 Interventional Results available

This Study Will Evaluate the Efficacy and Safety of LCZ696 Compared to Enalapril on Morbidity and Mortality of Patients With Chronic Heart Failure

ClinicalTrials.gov ID: NCT01035255

Public ClinicalTrials.gov record NCT01035255. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 20, 2026, 3:22 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Multicenter, Randomized, Double-blind, Parallel Group, Active-controlled Study to Evaluate the Efficacy and Safety of LCZ696 Compared to Enalapril on Morbidity and Mortality in Patients With Chronic Heart Failure and Reduced Ejection Fraction

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The study will evaluate the efficacy and safety of LCZ696 compared to enalapril on morbidity and mortality in patients with chronic heart failure (NYHA Class II - IV and EF =\< 35%).

Study identification

NCT ID
NCT01035255
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 3
Lead sponsor
Novartis Pharmaceuticals
Industry
Enrollment
8,442 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Dec 2009 (Type not available)
Primary completion
May 2014 (Actual)
Completion
May 2014 (Actual)
Last update posted
Aug 15, 2016

2009 – 2014

United States locations

U.S. sites
155
U.S. states
40
U.S. cities
132
Facility City State ZIP Site status
Novartis Investigative Site Birmingham Alabama 35209 —
Novartis Investigative Site Birmingham Alabama 35211 —
Novartis Investigative Site Huntsville Alabama 35801 —
Novartis Investigative Site Mobile Alabama 36608 —
Novartis Investigative Site Muscle Shoals Alabama 35662 —
Novartis Investigative Site Anchorage Alaska 99508 —
Novartis Investigative Site Gilbert Arizona 85234 —
Novartis Investigative Site Phoenix Arizona 85006 —
Novartis Investigative Site Phoenix Arizona 85020 —
Novartis Investigative Site Little Rock Arkansas 72204 —
Novartis Investigative Site Little Rock Arkansas 72205 —
Novartis Investigative Site Anaheim California 92801 —
Novartis Investigative Site Bellflower California 90706 —
Novartis Investigative Site Berkley California 94705 —
Novartis Investigative Site Loma Linda California 92357 —
Novartis Investigative Site Los Angeles California 90033 —
Novartis Investigative Site Los Angeles California 90073 —
Novartis Investigative Site Mather California 95655 —
Novartis Investigative Site Oceanside California 92056 —
Novartis Investigative Site Palm Springs California 92262 —
Novartis Investigative Site Pomona California 91767 —
Novartis Investigative Site Sacramento California 95816 —
Novartis Investigative Site San Diego California 92103 —
Novartis Investigative Site San Diego California 92161 —
Novartis Investigative Site Santa Rosa California 95405 —
Novartis Investigative Site Stockton California 95204 —
Novartis Investigative Site Tustin California 92780 —
Novartis Investigative Site Denver Colorado 80206 —
Novartis Investigative Site Denver Colorado 80220 —
Novartis Investigative Site Stamford Connecticut 06905 —
Novartis Investigative Site Washington D.C. District of Columbia 20422 —
Novartis Investigative Site Boynton Beach Florida 33472-2952 —
Novartis Investigative Site Davie Florida 33324 —
Novartis Investigative Site Fort Lauderdale Florida 33316 —
Novartis Investigative Site Gainesville Florida 32608 —
Novartis Investigative Site Jacksonville Florida 32209-6511 —
Novartis Investigative Site Jacksonville Florida 32216 —
Novartis Investigative Site Jacksonville Florida 32223 —
Novartis Investigative Site Lakeland Florida 33805 —
Novartis Investigative Site Leesburg Florida 34748 —
Novartis Investigative Site Port Charlotte Florida 33952 —
Novartis Investigative Site Tamarac Florida 33321 —
Novartis Investigative Site Tampa Florida 33609 —
Novartis Investigative Site Covington Georgia 30014 —
Novartis Investigative Site Decatur Georgia 30030 —
Novartis Investigative Site Honolulu Hawaii 96813 —
Novartis Investigative Site Honolulu Hawaii 96817 —
Novartis Investigative Site Chicago Illinois 60612 —
Novartis Investigative Site Maywood Illinois 60153 —
Novartis Investigative Site Melrose Park Illinois 60160 —
Novartis Investigative Site Park Ridge Illinois 60068 —
Novartis Investigative Site Quincy Illinois 62301 —
Novartis Investigative Site Des Moines Iowa 50314 —
Novartis Investigative Site Pratt Kansas 67124 —
Novartis Investigative Site Topeka Kansas 66606 —
Novartis Investigative Site Wichita Kansas 67207 —
Novartis Investigative Site Alexandria Louisiana 71301 —
Novartis Investigative Site Covington Louisiana 70433 —
Novartis Investigative Site Lafayette Louisiana 70501 —
Novartis Investigative Site Slidell Louisiana 70458 —
Novartis Investigative Site Biddeford Maine 04005 —
Novartis Investigative Site South Portland Maine 04106 —
Novartis Investigative Site Baltimore Maryland 21208 —
Novartis Investigative Site Beltsville Maryland 20705 —
Novartis Investigative Site Columbia Maryland 21044 —
Novartis Investigative Site Nottingham Maryland 21236 —
Novartis Investigative Site Ayer Massachusetts 01432 —
Novartis Investigative Site Boston Massachusetts — —
Novartis Investigative Site Haverhill Massachusetts 01830 —
Novartis Investigative Site Natick Massachusetts 01760 —
Novartis Investigative Site Ann Arbor Michigan 48106 —
Novartis Investigative Site Detroit Michigan 48202 —
Novartis Investigative Site Lapeer Michigan 48446 —
Novartis Investigative Site Saginaw Michigan 48601 —
Novartis Investigative Site Minneapolis Minnesota 55417 —
Novartis Investigative Site Saint Paul Minnesota 55102 —
Novartis Investigative Site Picayune Mississippi 39466 —
Novartis Investigative Site Rolling Fork Mississippi 39159 —
Novartis Investigative Site Springfield Missouri 65804 —
Novartis Investigative Site Springfield Missouri 65807 —
Novartis Investigative Site Fremont Nebraska 68025 —
Novartis Investigative Site Grand Island Nebraska 68803 —
Novartis Investigative Site Omaha Nebraska 68131 —
Novartis Investigative Site Nashua New Hampshire 03060 —
Novartis Investigative Site Elizabeth New Jersey 07202 —
Novartis Investigative Site Hamilton New Jersey 08690 —
Novartis Investigative Site New Brunswick New Jersey 08901 —
Novartis Investigative Site Newark New Jersey 07103-2714 —
Novartis Investigative Site Ocean City New Jersey 07712 —
Novartis Investigative Site Albuquerque New Mexico 87102 —
Novartis Investigative Site Cordtlandt Manor New York 10567 —
Novartis Investigative Site Laurelton New York 11422 —
Novartis Investigative Site New York New York 10032 —
Novartis Investigative Site Northport New York 11768 —
Novartis Investigative Site Asheboro North Carolina 27204 —
Novartis Investigative Site Asheville North Carolina 28803 —
Novartis Investigative Site Cary North Carolina 27511 —
Novartis Investigative Site Greensboro North Carolina 27401 —
Novartis Investigative Site Raleigh North Carolina 27610 —
Novartis Investigative Site Wilmington North Carolina 28401 —
Novartis Investigative Site Cadiz Ohio 43907 —
Novartis Investigative Site Canton Ohio 44710 —
Novartis Investigative Site Cincinnati Ohio 45219 —
Novartis Investigative Site Cincinnati Ohio 45267-0585 —
Novartis Investigative Site Cleveland Ohio 44195 —
Novartis Investigative Site Columbus Ohio 43210 —
Novartis Investigative Site Marion Ohio 43302 —
Novartis Investigative Site Bartlesville Oklahoma 74006 —
Novartis Investigative Site Oklahoma City Oklahoma 73104 —
Novartis Investigative Site Oklahoma City Oklahoma 73120 —
Novartis Investigative Site Stillwater Oklahoma 74074 —
Novartis Investigative Site Tulsa Oklahoma 74104-4243 —
Novartis Investigative Site Tulsa Oklahoma 74136 —
Novartis Investigative Site Portland Oregon 97239-3098 —
Novartis Investigative Site Aliquippa Pennsylvania 15001 —
Novartis Investigative Site Beaver Pennsylvania 15009 —
Novartis Investigative Site Philadelphia Pennsylvania 19102-1192 —
Novartis Investigative Site Pittsburgh Pennsylvania 15206 —
Novartis Investigative Site Charleston South Carolina 29401-5799 —
Novartis Investigative Site Rapid City South Dakota 57701 —
Novartis Investigative Site Memphis Tennessee 38104 —
Novartis Investigative Site Nashville Tennessee 37203 —
Novartis Investigative Site Nashville Tennessee 37212 —
Novartis Investigative Site Amarillo Texas 79106 —
Novartis Investigative Site Arlington Texas 76012 —
Novartis Investigative Site Beaumont Texas 77701 —
Novartis Investigative Site Beaumont Texas 77702 —
Novartis Investigative Site Brownsville Texas 78520 —
Novartis Investigative Site Dallas Texas 75231 —
Novartis Investigative Site Dallas Texas 75235 —
Novartis Investigative Site Dallas Texas 75251 —
Novartis Investigative Site Dallas Texas 75390 —
Novartis Investigative Site Grapevine Texas 76051 —
Novartis Investigative Site Houston Texas 77024 —
Novartis Investigative Site Houston Texas 77025 —
Novartis Investigative Site Houston Texas 77030 —
Novartis Investigative Site Houston Texas 77070 —
Novartis Investigative Site Houston Texas 77081 —
Novartis Investigative Site Kingwood Texas 77339 —
Novartis Investigative Site Livingston Texas 77351 —
Novartis Investigative Site Lufkin Texas 75904 —
Novartis Investigative Site Odessa Texas 79761 —
Novartis Investigative Site Plano Texas 75024 —
Novartis Investigative Site Tyler Texas 75701 —
Novartis Investigative Site Layton Utah 84041 —
Novartis Investigative Site Fredericksburg Virginia 22401 —
Novartis Investigative Site Richmond Virginia 23219 —
Novartis Investigative Site Richmond Virginia 23249 —
Novartis Investigative Site Seattle Washington 98103 —
Novartis Investigative Site Spokane Washington 99204 —
Novartis Investigative Site Tacoma Washington 98405 —
Novartis Investigative Site Madison Wisconsin 53792-1615 —
Novartis Investigative Site Milwaukee Wisconsin 53295 —
Novartis Investigative Site Waukesha Wisconsin 53188 —
Novartis Investigative Site Wausau Wisconsin 54401 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 876 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01035255, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Aug 15, 2016 · Synced Oct 20, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT01035255 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →